Ms contin and Movicol drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ms contin (morphine sulfate) and Movicol (polyethylene glycol 3350). Common drug interactions include abdominal pain among females and periarthritis among males.
The phase IV clinical study analyzes what interactions people have when they take Ms contin and Movicol. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Ms contin?
Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.
What is Movicol?
Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.
29 people who take Ms contin and Movicol together, and have interactions are studied.

What are the common drug interactions of Ms Contin and Movicol, by gender? *:
female:
- Abdominal pain
- Diarrhoea
- Gastrointestinal pain
- Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
- Bacteraemia (presence of bacteria in the blood)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Melaena (the passage of black, tarry stools)
- Nausea (feeling of having an urge to vomit)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Respiratory syncytial virus infection (viral disease of respiratory system)
male:
- Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
- Acute psychosis (period of mentally unstable behaviour)
- Suicidal ideation
- Urinary tract infection
- Demyelinating polyneuropathy (disorder that affects the nerves outside of the brain and spinal cord (peripheral nerves))
- Fear
- Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site)
- Injection site pain
- Injection site reaction
- Renal impairment (severely reduced kidney function)
What are the common drug interactions of Ms Contin and Movicol, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Respiratory syncytial virus infection (viral disease of respiratory system)
30-39:
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
40-49:
- Renal impairment (severely reduced kidney function)
50-59:
n/a
60+:
- Periarthritis (inflammation of the external coats of an artery and of the tissues around the artery)
- Urinary tract infection
- Gastrointestinal pain
- Intentional self-injury
- Pain in extremity
- Pulmonary oedema (fluid accumulation in the lungs)
- Suicidal ideation
- Lumbar spinal stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone)
- Bacteraemia (presence of bacteria in the blood)
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.69%
- Back Pain: 4 people, 13.79%
- Multiple Myeloma (cancer of the plasma cells): 4 people, 13.79%
- Renal Cell Carcinoma (a kidney cancer): 4 people, 13.79%
- Prostate Cancer Metastatic: 3 people, 10.34%
- Stress And Anxiety: 2 people, 6.90%
- High Blood Cholesterol: 2 people, 6.90%
- Cough: 2 people, 6.90%
- Depression: 2 people, 6.90%
- Dry Mouth: 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Ms contin and Movicol?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ms contin and Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ms contin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Movicol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ms contin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Movicol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on morphine sulfate and polyethylene glycol 3350 (the active ingredients of Ms contin and Movicol, respectively), and Ms contin and Movicol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Irbesartan and Caspofungin Acetate - 6 seconds ago
- Could Coreg cause Arteriosclerosis Coronary Artery? - 7 seconds ago
- Could Emtricitabine cause Hepatotoxicity Aggravated? - 14 seconds ago
- Drug interactions of Nystatin and Bentyl - 22 seconds ago
- Drug interactions of Turmeric and Diclofenac Potassium - 29 seconds ago
- Drug interactions of Alprazolam and Bisacodyl - 40 seconds ago
- Could Simvastatin cause Bradycardia? - 51 seconds ago
- Could Levothroid cause Cardiac Failure Aggravated? - a minute ago
- Drug interactions of Fentanyl Citrate and Soma - a minute ago
- Could Emend cause Malaise? - a minute ago